FIELD: chemistry.
SUBSTANCE: present invention relates to compounds of formula II:
.
EFFECT: novel compounds of formula II are obtained, which can be used in method of inhibiting nicotinamide-phosphoribosyltransferase "NAMPT", as well as pharmaceutical compositions based thereon.
17 cl, 3 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
NEW COMPOUNDS AND COMPOSITIONS FOR NAMPT INHIBITION | 2011 |
|
RU2617988C2 |
NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITING NAMPT | 2011 |
|
RU2617424C2 |
HETEROCYCLIC INHIBITORS OF Hh-SYGNAL CASCADE, BASED ON THEM MEDICINAL COMPOSITIONS AND METHOD OF TREATING DISEASES INDUCED BY ABBARANT ACTIVITY OF Hh-SIGNAL SYSTEM | 2007 |
|
RU2364597C1 |
TRICYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND USING THEM FOR TREATING IMMUNOLOGICAL AND ONCOLOGICAL COMPOUNDS | 2009 |
|
RU2545023C9 |
THERAPEUTIC ANTIDIABETIC AGENT | 2006 |
|
RU2438671C2 |
TRICYCLIC JANUS KINASE 1 INHIBITORS, COMPOSITIONS, METHODS OF PRODUCTION AND USE THEREOF | 2019 |
|
RU2824349C2 |
CERTAIN PROTEIN KINASE INHIBITORS | 2015 |
|
RU2671494C2 |
COMPOUNDS AND METHODS FOR KINASE MODULATION AND INDICATIONS FOR THEIR USE | 2013 |
|
RU2666146C2 |
PRIMARY AMINE DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES | 2012 |
|
RU2596867C2 |
CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND USE THEREOF IN TREATING PSYCHOTIC DISORDERS | 2011 |
|
RU2586974C2 |
Authors
Dates
2017-04-25—Published
2011-09-02—Filed